A Mathew

Manuscripts that are “Published at Acceptance” have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear prior to being copy edited or formatted in the style guide of this Journal. The contents of the manuscript may change before it is published in its final form. While accepted manuscripts are not yet assigned a volume, issue, or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. Manuscripts in this section will be removed once they have been assigned to a volume and issue, but will still retain the DOI and date of e-publication.

Total Lymphocyte Count and Haemoglobin Concentration Combined as a Surrogate Marker for Initiating Highly Active Antiretroviral Therapy in a Resource-limited Setting as against CD4 Cell Count

Issue:

Vol 63, Issue 5: Sep (2014)

DOI:

10.7727/wimj.2013.132

Pages:

460–4

Synopsis:

Adding haemoglobin to total lymphocyte count improves the sensitivity of the marker to predict CD4 count <200/mm3, thus ensuring initiation of highly active antiretroviral therapy and thereby reducing investigational costs.

ABSTRACT

Aim: To find a sensitive and low-cost surrogate marker for CD₄ count for initiating highly active antiretroviral therapy (HAART) [CD₄ < 200 /mm³], in the form of total lymphocyte count (TLC) < 1200 /mm³ combined with haemoglobin (Hb) with multiple Hb cut-offs.

Received:

09 Sep, 2013

Accepted:

29 Oct, 2013

PDF Attachment:

dhamangaonkar_et_al-surrogate_markers_for_cd4_count_for_initiating_haart.pdf

Journal Sections:

Original Articles

Keywords:

HIV

Haemoglobin

total lymphocyte count